UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/07: (KODK) (CKH) Higher; (RIDE) (XPEV) (JKS) Lower (more...)
-
-
-
-
-
-
-
UBS Upgrades Gilead Sciences (GILD) to Buy; 'Turning the Corner'
-
-
-
-
-
-
-
UBS Maintains Bullish View Following Gilead (GILD) Management Meetings
-
-
-
-
-
-
-
UBS Remains Bullish on Biotech; Achillion Pharma (ACHN) PT Raised to $15 (AMGN) (CELG) (GILD) (MDVN)
-
-
-
-
-
-
-
Gilead Sciences (GILD) Higher as UBS Raises Target
-
-
-
-
-
-
-
UBS Maintains a 'Buy' on Gilead Sciences (GILD); Raising PT on Lower Risk to HCV
-
-
-
-
-
-
-
UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Survey: ART Switching Should Increase
-
126,090 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All